Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 1
2016 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Encuestas de satisfacción al personal facultativo y de enfermería como método de mejora de la calidad de los procesos del servicio de farmacia.
Giménez Manzorro A, Vigil D, Durán García ME, Fernández-Llamazares CM, Lobato Matilla E, Caro González L, Sanjurjo M. Giménez Manzorro A, et al. Among authors: lobato matilla e. Rev Calid Asist. 2008 Jan;23(1):3-6. doi: 10.1016/S1134-282X(08)70459-7. Epub 2008 Oct 11. Rev Calid Asist. 2008. PMID: 23040037 Spanish.
Implementation of a parenteral nutrition home care programme in a tertiary hospital.
Arhip L, Camblor M, Bretón I, Motilla de la Cámara M, Serrano-Moreno C, Romero Jiménez RM, Lobato Matilla E, Frías Soriano L, Velasco Gimeno C, Carrascal Fabián ML, Cuerda C. Arhip L, et al. Among authors: lobato matilla e. Nutr Hosp. 2023 Jun 21;40(3):476-484. doi: 10.20960/nh.04494. Nutr Hosp. 2023. PMID: 37154026 Free article. English.
[Fuller's earth, "banished" from herbicide poisoning].
de Lorenzo-Pinto A, García Sánchez R, Lobato Matilla E, Herranz Alonso A. de Lorenzo-Pinto A, et al. Among authors: lobato matilla e. Med Clin (Barc). 2013 Sep 7;141(5):231. doi: 10.1016/j.medcli.2013.01.028. Epub 2013 Mar 26. Med Clin (Barc). 2013. PMID: 23537737 Spanish. No abstract available.
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare.
Romero-Jimenez R, Escudero-Vilaplana V, Chamorro-de-Vega E, Ais-Larisgoitia A, Lobato-Matilla E, Somoza-Fernández B, Ruiz-Briones P, González C, Baniandrés O, Menchén L, Lobo-Rodríguez C, Herranz A, Sanjurjo M. Romero-Jimenez R, et al. Among authors: lobato matilla e. Front Immunol. 2022 Jul 28;13:915578. doi: 10.3389/fimmu.2022.915578. eCollection 2022. Front Immunol. 2022. PMID: 35967330 Free PMC article.
Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study.
Ramírez E, Romero-Jiménez R, Hernández-Muniesa B, Fernández-Pacheco M, Calvo A, Chamorro-de-Vega E, Herrero N, Úbeda B, Morell A, Ais-Larisgoitia A, Lobato-Matilla E, Muñoz Á, Casado A, Casado MÁ, Escudero-Vilaplana V. Ramírez E, et al. Among authors: lobato matilla e. J Clin Pharm Ther. 2022 Dec;47(12):2020-2029. doi: 10.1111/jcpt.13742. Epub 2022 Aug 5. J Clin Pharm Ther. 2022. PMID: 35929568
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.
Chamorro-de-Vega E, Rodriguez-Gonzalez CG, Manrique-Rodríguez S, Lobato-Matilla E, García-Moreno F, Olmedo M, Correa-Rocha R, Valerio M, Aldámiz-Echevarria T, Machado M, Sancho-Gonzalez M, Lopez-Bernaldo-de-Quirós JC, Ruiz-Briones P, Romero-Jiménez R, Sarobe-González C, Gimenez-Manzorro A, Collado-Borrell R, Fernandez-Llamazares CM, Revuelta-Herrero JL, Somoza-Fernandez B, Garcia-Sanchez S, Taladriz-Sender I, Bouza E, Herranz A, Muñoz P, Sanjurjo M. Chamorro-de-Vega E, et al. Among authors: lobato matilla e. Expert Rev Clin Pharmacol. 2021 Feb;14(2):249-260. doi: 10.1080/17512433.2021.1875819. Epub 2021 Jan 26. Expert Rev Clin Pharmacol. 2021. PMID: 33499687 Free PMC article.
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice.
Chamorro-de-Vega E, Gimenez-Manzorro A, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, Collado Borrell R, Ibañez-Garcia S, Lallana Sainz E, Lobato Matilla E, Lorenzo-Pinto A, Manrique-Rodriguez S, Fernandez-Llamazares CM, Marzal-Alfaro M, Ribed A, Romero Jimenez RM, Sarobe Gonzalez C, Herranz A, Sanjurjo M. Chamorro-de-Vega E, et al. Among authors: lobato matilla e. Ann Pharmacother. 2016 Nov;50(11):901-908. doi: 10.1177/1060028016659306. Epub 2016 Jul 20. Ann Pharmacother. 2016. PMID: 27422641